Resources

Clinical trials:

Antidote's user-friendly Clinical Trial Navigator
The National Cancer Institute's listing of clinical trials: http://www.cancer.gov/clinicaltrials
Bristol-Myers Squibb Study Connect: https://www.bmsstudyconnect.com/us/en/home.html

General information:

National Cancer Institute Melanoma homepage: http://www.cancer.gov/cancertopics/types/melanoma
Melanoma. The Mayo Clinic: http://www.mayoclinic.com/health/melanoma/DS00439
Melanoma treatment. PubMed Health. U.S. National Library of Medicine. National Institutes of Health:
http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0032763
The Skin Cancer Foundation: http://www.skincancer.org
American Academy of Dermatology: http://www.aad.org/dermatology-a-to-z/diseases-and-treatments/q---t/skin-cancer
American Cancer Society: http://www.cancer.org/cancer/skincancer-melanoma/index
Cancer.net: http://www.cancer.net/cancer-types/melanoma

Information on some approved melanoma drugs and treatments:*
Immunotherapy drugs:
   CTLA-4 inhibitor:
     Yervoy (ipiluminab): http://www.yervoy.com/patient.aspx

     PD-1 inhibitors:
  Keytruda (pembrolizumab): https://www.keytruda.com/melanoma/how-keytruda-works/index.xhtm
Opdivo (nivolumab): http://www.bmscustomerconnect.com

   Oncolytic virus therapy:
Imlygic (talimogene/T-VEC): http://www.cancer.gov/about-cancer/treatment/drugs/talimogenelaherparepvec

Targeted therapy drugs:
BRAF and MEK inhibitors:
Zelboraf (vemurafenib): http://www.zelboraf.com/patient/
Tafinlar (dabrafenib): http://www.nlm.nih.gov/medlineplus/druginfo/meds/a613038.html
Mekinist (trametinib): http://www.cancer.gov/cancertopics/druginfo/trametinib
Cotellic (cobimetinib): http://www.cancer.gov/about-cancer/treatment/drugs/cobimetinib

TIL therapy: https://www.curemelanoma.org/blog/article/til-therapy-in-melanoma-where-we-stand

*This list is not exhaustive. Clinical trials for new drugs and combinations of treatments are ongoing, and new FDA approvals continue to occur. Work with your oncologist to find the best treatment options for you.

Online support community:

The Melanoma Research Alliance's Melanoma Exchange provides a critical platform for finding support and asking questions related to melanoma, melanoma treatment and relevant research, including clinical trials. Group members share personal experiences and insight, the latest treatment news, dispel rumors about clinical trials, and more in this supportive setting. Content is curated by patients who have had direct experience in clinical trials and Melanoma Research Alliance staff.
http://melanoma.inspire.com

Call to Action to Prevent Skin Cancer
In July of 2014, the U.S. Department of Health and Human Services released the Surgeon General's Call to Action to Prevent Skin Cancer. This remarkable document marks the first time the Surgeon General's office has declared openly that UV radiation is harmful and that people need to protect themselves from its effects. It also lays out an action plan to stem the "rising tide of skin cancer" that has seen the incidence of melanoma alone triple over the last 35 years.

The CDC issues yearly editions of its Skin Cancer Prevention Report. The report includes a wealth of statistics and useful information on efforts to prevent skin cancer.